Tirzepatide is the first approved dual GLP-1/GIP agonist and achieves greater weight loss and glycaemic improvement than semaglutide alone, suggesting synergistic incretin modulation 12
Do not exceed recommended dosage
This helps sustain skin brightness while avoiding over-treatment
du Plessis L1, Laubscher P, Jooste J, du Plessis J, Franken A, van Aarde N, Eloff F
In another study that examined the molecular mechanisms behind the effects of liraglutide on oxidized low-density lipoprotein in endothelial cells [68], liraglutide was found to suppress LDL-induced immune cell adhesion to the endothelial cells by inhibiting the expression of vascular adhesion molecules including E-selectin and VCAM-1 both of which have been related to the development of atherosclerosis [68,69,70,71] (refer to Figure one)
Theres evidence that these forms are good for your brain and heart and even for disease prevention